Live Panel Discussion Featuring Leading Telehealth and Diabetes Experts

Diabetes clinics are overwhelmed as a result of physician shortages and operational bottlenecks, which have been exacerbated by COVID-19. As a result, too few people with diabetes have access to quality specialty care they require on a regular basis. The current pandemic has added another layer of complexity, but also presents a tremendous opportunity to extend support to people with diabetes by incorporating virtual care.

Nationwide, over 50 universities and hospitals are receiving support from the Helmsley Charitable Trust for their diabetes clinics to help them manage through the COVID-19 crisis. Helmsley has also contracted with Cecelia Health so that those clinics that want extra bandwidth as they shift to telehealth can avail themselves of Cecelia’s expertise in helping people manage insulin-dependent diabetes, ease the daily burden of living with the condition, and help improve outcomes. For those clinics accessing virtual care, it is an indispensable complement to in-person visits as endocrinologists and clinicians rethink their approaches for successfully managing diabetes.

This moderated live panel will provide an opportunity to learn how clinics are incorporating telehealth models, and laying a foundation for the future of diabetes specialty care.


Speakers

Dr. Ruth Weinstock

Medical Director

The Joslin Diabetes Center
SUNY Upstate Medical University

 

David Panzirer

Trustee

Helmsley Charitable Trust

Dr. Susan Beane

Vice President and Executive Medical Director

Healthfirst

David Weingard

Chief Executive Officer
and Founder

Cecelia Health


Amy T

Moderator

Amy Tenderich

Founder and Editor-in-Chief of DiabetesMine, a leading online information destination for people with diabetes and one of the top health blogs around the country and the world.


Discussion Topics Include:

  • Value of telehealth in providing access to high quality, affordable diabetes and mental health care
  • Patient and clinical impact of successfully implementing a telehealth model
  • Managing a rapidly growing diabetes population and associated treatment costs

 

The panel discussion will conclude with an open Q&A session.


Attendees will takeaway strategies for implementing virtual diabetes care programs:

  • Prepping people with diabetes for telemedicine visits
  • Assistance with data downloads, education and insights on patterns/trends to increase quality & efficiency of provider visits.
  • Initiating, troubleshooting and increasing success with Continuous Glucose Monitors (CGM), Blood Glucose Monitors (BGM), insulin pump and pen technologies
  • Recommending dosage and titration changes and facilitating follow-up with endocrinologists
  • Providing support and education to caregivers as well as people with T1 & T2 diabetes
  • Supporting meaningful behavior or lifestyle changes
  • Clearing mental health barriers to achieving great outcomes and quality of life